Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Hemorrhagic Shock Global Clinical Trials Review, H2, 2013

November 27, 2013

Reportbuyer.com just published a new market research report: Hemorrhagic Shock Global Clinical Trials Review, H2, 2013.

London (PRWEB) November 27, 2013

Hemorrhagic Shock Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, “Hemorrhagic Shock Global Clinical Trials Review, H2, 2013" provides data on the Hemorrhagic Shock clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemorrhagic Shock. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hemorrhagic Shock. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

-Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

-Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

-Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

-Understand the dynamics of a particular indication in a condensed manner

-Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

-Obtain discontinued trial listing for trials across the globe

-Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Hemorrhagic Shock 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by BRIC Nations 15

Clinical Trials by G7 Nations 16

Clinical Trials in G7 Nations by Trial Status 17

Clinical Trials by E7 Nations 18

Clinical Trials in E7 Nations by Trial Status 19

Clinical Trials by Phase 20

In Progress Trials by Phase 21

Clinical Trials by Trial Status 22

Unaccomplished Trials of Hemorrhagic Shock 23

Subjects Recruited Over a Period of Time 24

Prominent Sponsors 25

Top Companies Participating in Hemorrhagic Shock Therapeutics Clinical Trials 27

Prominent Drug Comparison 29

Clinical Trial Profiles 30

Clinical Trial Overview of Top Companies 30

Sangart, Inc. 30

Clinical Trial Overview of Sangart, Inc. 30

AstraZeneca PLC 31

Clinical Trial Overview of AstraZeneca PLC 31

Shenzhen Neptunus Pharmaceutical Company Limited 32

Clinical Trial Overview of Shenzhen Neptunus Pharmaceutical Company Limited 32

Health Ricerca e Sviluppo S.r.l 33

Clinical Trial Overview of Health Ricerca e Sviluppo S.r.l 33

Innogene Kalbiotech Pte. Ltd. 34

Clinical Trial Overview of Innogene Kalbiotech Pte. Ltd. 34

Northfield Laboratories Inc. (Inactive) 35

Clinical Trial Overview of Northfield Laboratories Inc. (Inactive) 35

Oxygen Biotherapeutics, Inc. 36

Clinical Trial Overview of Oxygen Biotherapeutics, Inc. 36

Clinical Trial Overview of Top Institutes / Government 37

Imperial College London 37

Clinical Trial Overview of Imperial College London 37

Denver Health and Hospital Authority 38

Clinical Trial Overview of Denver Health and Hospital Authority 38

University of California, San Francisco 39

Clinical Trial Overview of University of California, San Francisco 39

University of Pittsburgh 40

Clinical Trial Overview of University of Pittsburgh 40

Japanese Association for the Surgery of Trauma 41

Clinical Trial Overview of Japanese Association for the Surgery of Trauma 41

Southern Medical University 42

Clinical Trial Overview of Southern Medical University 42

Wolfson Medical Center 43

Clinical Trial Overview of Wolfson Medical Center 43

Ottawa Hospital Research Institute 44

Clinical Trial Overview of Ottawa Hospital Research Institute 44

The University of Texas Southwestern Medical Center at Dallas 45

Clinical Trial Overview of The University of Texas Southwestern Medical Center at Dallas 45

Baylor College of Medicine 46

Clinical Trial Overview of Baylor College of Medicine 46

Assistance Publique Hopitaux De Marseille 47

Clinical Trial Overview of Assistance Publique Hopitaux De Marseille 47

University of Virginia 48

Clinical Trial Overview of University of Virginia 48

Innsbruck Medical University 49

Clinical Trial Overview of Innsbruck Medical University 49

National Institute of General Medical Sciences 50

Clinical Trial Overview of National Institute of General Medical Sciences 50

The University of Texas Health Science Center at San Antonio 51

Clinical Trial Overview of The University of Texas Health Science Center at San Antonio 51

Sunnybrook Health Sciences Centre 52

Clinical Trial Overview of Sunnybrook Health Sciences Centre 52

University of Washington 53

Clinical Trial Overview of University of Washington 53

University of Missouri 54

Clinical Trial Overview of University of Missouri 54

Five Key Clinical Profiles 55

Appendix 87

Abbreviations 87

Definitions 87

Research Methodology 88

Secondary Research 88

About GlobalData 89

Contact Us 89

Disclaimer 89

Source 90

List of Tables

Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7

Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8

Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9

Hemorrhagic Shock Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10

Hemorrhagic Shock Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11

Hemorrhagic Shock Therapeutics Clinical Trials, North America, Top Countries, 2013* 12

Hemorrhagic Shock Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 13

Hemorrhagic Shock Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 14

Hemorrhagic Shock Therapeutics Clinical Trials, BRIC Countries, 2013* 15

Hemorrhagic Shock Therapeutics Clinical Trials, G7 Countries, 2013* 16

Hemorrhagic Shock Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17

Hemorrhagic Shock Therapeutics Clinical Trials, E7 Countries, 2013* 18

Hemorrhagic Shock Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19

Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20

Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21

Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22

Hemorrhagic Shock Therapeutics Market, Global, Terminated Clinical Trials, 2013* 23

Hemorrhagic Shock Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 24

Hemorrhagic Shock Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 26

Hemorrhagic Shock Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 28

Hemorrhagic Shock Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 29

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Sangart, Inc., 2013* 30

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 31

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Shenzhen Neptunus Pharmaceutical Company Limited, 2013* 32

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Health Ricerca e Sviluppo S.r.l, 2013* 33

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Innogene Kalbiotech Pte. Ltd., 2013* 34

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Northfield Laboratories Inc. (Inactive), 2013* 35

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Oxygen Biotherapeutics, Inc., 2013* 36

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2013* 37

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Denver Health and Hospital Authority, 2013* 38

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2013* 39

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 40

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Association for the Surgery of Trauma, 2013* 41

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Southern Medical University, 2013* 42

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Wolfson Medical Center, 2013* 43

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2013* 44

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Southwestern Medical Center at Dallas, 2013* 45

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2013* 46

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique Hopitaux De Marseille, 2013* 47

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2013* 48

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Innsbruck Medical University, 2013* 49

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of General Medical Sciences, 2013* 50

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at San Antonio, 2013* 51

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunnybrook Health Sciences Centre, 2013* 52

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2013* 53

Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2013* 54

List of Figures

Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7

Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8

Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9

Hemorrhagic Shock Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10

Hemorrhagic Shock Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11

Hemorrhagic Shock Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12

Hemorrhagic Shock Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 13

Hemorrhagic Shock Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 14

Hemorrhagic Shock Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15

Hemorrhagic Shock Therapeutics Clinical Trials, G7 Countries (%), 2013* 16

Hemorrhagic Shock Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17

Hemorrhagic Shock Therapeutics Clinical Trials, E7 Countries (%), 2013* 18

Hemorrhagic Shock Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19

Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20

Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21

Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22

Hemorrhagic Shock Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 24

Hemorrhagic Shock Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 25

Hemorrhagic Shock Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 27

Hemorrhagic Shock Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 29

GlobalData Methodology 88

Read the full report:

Hemorrhagic Shock Global Clinical Trials Review, H2, 2013

http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trials/hemorrhagic_shock_global_clinical_trials_review.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

For more information:

Sarah Smith

Research Advisor at Reportbuyer.com

Email: query@reportbuyer.com

Tel: +44 208 816 85 48

Website: http://www.reportbuyer.com

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/11/prweb11375663.htm


Source: prweb